| Literature DB >> 30898086 |
Meshal Aldohyan1, Nedal Al-Rawashdeh2,3, Farouk M Sakr4, Saeed Rahman5, Ali I Alfarhan5, Mahmoud Salam6.
Abstract
BACKGROUND: Knowledge transfer of Middle East respiratory syndrome coronavirus (MERS-CoV) involves the dissemination of created/acquired information on MERS-CoV in hospitals, making this information accessible to all healthcare workers (HCWs). This study evaluated the perceived effectiveness of MERS-CoV educational programs and knowledge transfer among primary care HCWs at a hospital in Saudi Arabia that witnessed the largest outbreak of confirmed MERS-CoV cases in this country.Entities:
Keywords: Coronavirus; Education; Knowledge transfer; MERS; Primary health
Mesh:
Year: 2019 PMID: 30898086 PMCID: PMC6427879 DOI: 10.1186/s12879-019-3898-2
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Health care workers’ and outcomes’ characteristics
| n(%) | |
|---|---|
| Gender | |
| Male | 145 (35.9%) |
| Female | 259 (64.1%) |
| Age (years) | |
| ≤ 30 | 107 (26.5%) |
| 30–40 | 116 (28.7%) |
| > 40 | 181 (44.8%) |
| Job title | |
| Physician | 93 (23.0%) |
| Nurse | 188 (46.5%) |
| Pharmacist | 73 (18.1%) |
| Technical | 50 (12.4%) |
| Experience (years) | |
| < 5 | 118 (29.2%) |
| 5–10 | 116 (28.7%) |
| > 10 | 170 (42.1%) |
| Percentage Mean Score of Knowledge | |
| (Mean ± SD) | 71.1 ± 19.4 |
| Perception towards effectiveness of MERS CoV educational programs | |
| Negative | 91 (22.5%) |
| Positive | 313 (77.5%) |
| Perception towards knowledge transfer of MERS CoV updates | |
| Negative | 84 (20.8%) |
| Positive | 320 (79.2%) |
n frequency, % percentage, SD standard deviation
Frequency of wrong responses to individual knowledge statements
| n(%) | ||
|---|---|---|
| 1 | Incubation time for virus is 14–28 days | 337 (83.4%) |
| 2 | Antibiotics are the first line treatment for the management of MERS-CoV | 176 (43.6%) |
| 3 | Polymerase chain reaction can be used to diagnose MERS-CoV | 163 (40.3%) |
| 4 | Washing hands vigorously (soap/water) for 20 s helps in prevention/transmission of disease | 130 (32.2%) |
| 5 | Vaccination of MERS-CoV is available in market | 98 (24.3%) |
| 6 | MERS-CoV is caused by alpha coronavirus | 95 (23.5%) |
| 7 | The main source of MERS virus is plant | 86 (21.3%) |
| 8 | Transmission of MERS-CoV infection can be prevented by using universal precautions. | 82 (20.3%) |
| 9 | MERS patients should be kept in isolation | 78 (19.3%) |
| 10 | Gowns, gloves, mask and goggles must be used when dealing with MERS patients | 75 (18.6%) |
| 11 | People with co-morbidities are more likely to be infected | 73 (18.1%) |
| 12 | Special caution must be taken if a person presents with MERS symptoms from the Arabian Peninsula | 72 (17.8%) |
| 13 | MERS-CoV patients develop severe acute respiratory illness | 61 (15.1%) |
| 14 | MERS-CoV spreads through close contact like caring and/or living with infected persons | 54 (13.4%) |
| 15 | Fever, cough and shortage of breath are hallmark symptoms of MERS-CoV | 47 (11.6%) |
| 16 | MERS-CoV can be fatal | 47 (11.6%) |
n frequency, % percentage
Perceived effectiveness of MERS-CoV educational programs and its knowledge transfer across particpant characteristics
| Perceived effectiveness of MERS CoV educational programs | Perception towards knowledge transfer of MERS CoV updates | |||
|---|---|---|---|---|
| Negative n(%) | Positive n(%) | Negative n(%) | Positive n(%) | |
| Gender | ||||
| Male | 52 (35.9%) | 93 (64.1%) | 47 (32.4%) | 98 (67.6%) |
| Female | 39 (15.1%) | 220 (84.9%) | 37 (14.3%) | 222 (85.7%) |
| χ2 = 23.05, | χ2 = 18.55, | |||
| Age (years) | ||||
| ≤ 30 | 30 (28.0%) | 77 (72.0%) | 28 (26.2%) | 79 (73.8%) |
| 30–40 | 18 (15.5%) | 98 (84.5%) | 23 (19.8%) | 93 (80.2%) |
| > 40 | 43 (23.8%) | 138 (76.2%) | 33 (18.2%) | 148 (81.8%) |
| χ2 = 5.285, | χ2 = 2.664, | |||
| Job title | ||||
| Physician | 30 (32.3%) | 63 (67.7%) | 31 (33.3%) | 62 (66.7%) |
| Nurse | 28 (14.9%) | 160 (85.1%) | 21 (11.2%) | 167 (88.8%) |
| Pharmacist | 24 (32.9%) | 49 (67.1%) | 23 (31.5%) | 50 (68.5%) |
| Technical | 9 (18.0%) | 41 (82.0%) | 9 (18.0%) | 41 (82.0%) |
| χ2 = 16.392, | χ2 = 24.776, | |||
| Experience (years) | ||||
| < 5 | 40 (33.9%) | 78 (66.1%) | 42 (35.4%) | 76 (64.6%) |
| 5–10 | 24 (20.7%) | 92 (79.3%) | 27 (23.3%) | 89 (76.7%) |
| > 10 | 27 (15.9%) | 143 (84.1%) | 15 (8.8%) | 155 (91.2%) |
| χ2 = 13.269, | χ2 = 30.918, | |||
n frequency, % percentage, χ2 Chi-square, P P-value, *: significance at < 0.05
Knowledge scores across various sample characteristics
| PMS Knowledge Mean ± SD | |
|---|---|
| Gender | |
| Male | 67.3 ± 23.4 |
| Female | 73.3 ± 16.5 |
| Z = -1.589, | |
| Age (years) | |
| ≤ 30 | 66.4 ± 20.7 |
| 30–40 | 72.0 ± 18.4 |
| > 40 | 73.4 ± 18.9 |
| χkwt = 10.51, df = 2, | |
| Job title | |
| Physician | 69.5 ± 24.2 |
| Nurse | 74.3 ± 14.0 |
| Pharmacist | 64.9 ± 23.2 |
| Technical | 71.3 ± 19.0 |
| χkwt = 5.644, df = 3, | |
| Experience (years) | |
| < 5 | 63.9 ± 22.5 |
| 5–10 | 70.0 ± 18.4 |
| > 10 | 76.9 ± 15.7 |
| χkwt = 28.39, df = 2, | |
| Perception towards effectiveness of MERS CoV educational programs | |
| Negative | 49.4 ± 20.7 |
| Positive | 77.3 ± 13.9 |
| Z = -10.43, | |
| Perception towards knowledge transfer of MERS CoV updates | |
| Negative | 46.0 ± 19.7 |
| Positive | 77.5 ± 13.2 |
| Z = -11.248, | |
n frequency, % percentage, Z Mann Whitney test, χ Kruskal–Wallis test, df degree of freedom, P P-value, *: significance at < 0.05
Significantly associated factors with negative perceptions towards MERS CoV educational programs and knowledge transfer
| Negative perception towards effectiveness of MERS CoV educational programs | Negative perception towards knowledge transfer of Mers CoV updates | |||||
|---|---|---|---|---|---|---|
| β (S.E.) | Adj. | Adj.OR[95% CI] | β (S.E.) | Adj.P-value | Adj.OR[95% CI] | |
| Sex | 0.89 (0.28) | 0.001* | 2.4 [1.4–4.2] | 0.67 (0.29) | 0.023* | 2.0 [1.1–3.5] |
| Specialty of physician | 0.58 (0.28) | 0.038* | 1.8 [1.03–3.11] | 1.02 (0.30) | 0.001* | 2.8 [1.6–5.0] |
| Experience (years) | 0.74 (0.27) | 0.005* | 2.1 [1.3–3.5] | 1.6 (0.32) | < 0.001* | 4.9 [2.6–9.2] |
| Constant | −2.36 (0.27) | < 0.001* | 0.094 | −3.22 (0.35) | < 0.001* | 0.040 |
β coefficient of determination, S.E. standard error, adj. adjusted, OR odds ratio, CI confidence interval, P P-value, *: significance at < 0.05